tradingkey.logo
tradingkey.logo
Search

Canton Strategic Holdings Ord Shs

CNTN
Add to Watchlist
1.710USD
-0.090-5.00%
Close 11-13 16:00(ET)
136.25MMarket Cap
LossP/E TTM

About Canton Strategic Holdings Ord Shs Company

Tharimmune, Inc. is a clinical-stage biotechnology company. The Company is engaged in developing therapeutic candidates for inflammatory and immunologic conditions with unmet need. It has a transmucosal film product, TH104, is a Phase II ready clinical candidate and an oral biologic as well as two bispecific biologics in pre-clinical development. TH104 is a transmucosal buccal film embedded with the active compound nalmefene onto a thin film which adheres inside of the mouth on the cheek and biodegrades. TH104 is an ideal product candidate for multiple liver-related and other pruritogenic inflammatory conditions. It is also developing an early-stage pipeline of novel therapeutic candidates targeting validated high value immune-oncology targets including human epidermal growth factor receptor 2, human EGF receptor 3 and programmed cell death protein. The Company is developing antibodies, including bispecific antibodies, antibody drug conjugates, among others.

Canton Strategic Holdings Ord Shs Profile

Ticker Symbol- -
Company name- -
IPO date- -
CEO- -
Number of employees- -
Security type- -
Fiscal year-end- -
Address- -
City- -
Stock exchange- -
Country- -
Postal code- -
Phone- -
Website- -
Ticker Symbol- -
IPO date- -
CEO- -

Company Executives of Canton Strategic Holdings Ord Shs

Name
Name/Position
Position
Shareholding
Change
,
,
--
--
Mr. Clay Kahler
Mr. Clay Kahler
Independent Director
Independent Director
--
--
Mr. Mark Wendland
Mr. Mark Wendland
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
--
--
Mr. Mark Toomey
Mr. Mark Toomey
President
President
--
--
Mr. Jacob Asbury
Mr. Jacob Asbury
Chief Financial Officer
Chief Financial Officer
--
--
Ms. Angela Dominy Radkowski
Ms. Angela Dominy Radkowski
Chief Operating Officer
Chief Operating Officer
--
--
Ms. Jill E. Sommers
Ms. Jill E. Sommers
Independent Director
Independent Director
--
--
Mr. William Wiley
Mr. William Wiley
Independent Director
Independent Director
--
--
Mr. Sean P. Galvin
Mr. Sean P. Galvin
Independent Director
Independent Director
--
--
Ms. Pamela Lynn Carter
Ms. Pamela Lynn Carter
Independent Director
Independent Director
--
--
View more
Name
Name/Position
Position
Shareholding
Change
,
,
--
--
Mr. Clay Kahler
Mr. Clay Kahler
Independent Director
Independent Director
--
--
Mr. Mark Wendland
Mr. Mark Wendland
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
--
--
Mr. Mark Toomey
Mr. Mark Toomey
President
President
--
--
Mr. Jacob Asbury
Mr. Jacob Asbury
Chief Financial Officer
Chief Financial Officer
--
--
Ms. Angela Dominy Radkowski
Ms. Angela Dominy Radkowski
Chief Operating Officer
Chief Operating Officer
--
--

FAQs

Who are the top five shareholders of Canton Strategic Holdings Ord Shs?

The top five shareholders of Canton Strategic Holdings Ord Shs are: ,
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.